Publications by authors named "Suheil Nasrallah"
Article Synopsis
- A study investigated the relationship between pre-treatment platelet counts and outcomes in breast cancer patients, finding notable differences in platelet levels among those who survived versus those who died or had recurrences.
- Researchers analyzed data from 22 stage I, 22 stage II, and 9 stage III/IV breast cancer patients over a follow-up period of 12 months to 5 years.
- The results suggest that lower pre-treatment platelet counts may indicate poorer prognosis, potentially linked to a cancer-related consumption process affecting clotting factors.
Background And Objectives: Gemcitabine is an active agent in pancreatic cancer, with known radiosensitizing properties. Therefore, a phase II study was conducted to evaluate the efficacy of gemcitabine combined with radiation therapy in patients with localized unresectable adenocarcinoma of the pancreas.
Methods: Weekly gemcitabine at a dose of 1,000 mg/m(2) for 7 weeks was given as an induction phase.